What question did this study set out to answer?

April 10, 2026Open Access

Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study

Key Points

This research aims to explore treatment patterns in patients with systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD) after disease progression.
Retrospective observational study design
Analysis of post-progression treatment strategies
Focus on corticosteroids, DMARDs, and antifibrotics
High reliance on corticosteroids post-progression
Limited use of DMARDs and antifibrotics observed
Indicates a gap in treatment practices versus optimal management guidelines

Abstract

The high use of corticosteroids and limited use of DMARDs and antifibrotics post-progression in this descriptive study implies a significant gap between current practice and optimal management of patients with SARD-ILD.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Joseph Yang

Boehringer Ingelheim (United States)

Katy Sadowski

Johns Hopkins University

Akshay Kharat

Boehringer Ingelheim (United States)

Journals

BMJ Open

Actions

Institutions

University of Alabama at Birmingham

Boehringer Ingelheim (United States)

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Also consider